Nephrogen vs Ekho
Side-by-side comparison of AI visibility scores, market position, and capabilities
SF YC W20 preclinical gene therapy for polycystic kidney disease (600K US patients) using AI-driven target identification; $1.1M raised with NIH SBIR grant, raising $4M seed competing with CRISPR Therapeutics for curative kidney genetic medicine.
About
Nephrogen is a San Francisco-based preclinical gene therapy company — backed by Y Combinator (W20) with $1.1 million in total funding including $775,000 raised to date plus a $325,000 NIH SBIR grant, and currently raising a $4 million seed round with support from StartX and 2048 Ventures — developing curative gene therapies for kidney diseases, with polycystic kidney disease (PKD) as the lead program targeting the 600,000 Americans with the autosomal dominant PKD subtype, an inherited kidney cyst disorder with no disease-modifying treatments that currently progresses to end-stage renal disease requiring dialysis or transplant in the majority of patients. Founded by researchers with combined expertise in AI-driven drug discovery, genetic engineering, and nephrology, Nephrogen applies AI target identification and gene therapy delivery to the largest category of rare inherited kidney diseases.
End-to-end vehicle commerce platform automating titling, registration, and compliance for OEM national sales; $17.3M from Activant, JPMorgan Payments, and Winnebago with 20+ OEM customers.
About
Ekho is an end-to-end vehicle commerce platform that provides digital sales infrastructure for automotive dealers and OEMs — handling the complete transaction lifecycle for nationwide vehicle sales including digital checkout, financing integration, titling, registration, and compliance management for vehicles sold across state lines. Founded and backed by Y Combinator, Activant Capital, JPMorgan Payments, and Winnebago Industries, Ekho raised $17.3 million total including a $15 million Series A, serving 20+ OEM customers including four publicly traded manufacturers.
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.